Skip to main content
ALNY logo
ALNY
(NASDAQ)
Alnylam Pharmaceuticals, Inc.
$268.74-- (--)
Loading... - Market loading

Alnylam Pharmaceuticals (ALNY) Stock Price & Financial Analysis

Alnylam Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$264.21 - $273.72
52-Week High$495.55
52-Week Low$266.43
Open$270.84
Volume1.10M
Average Volume (3M)1.47M
Market Cap36.90B
Shares Outstanding138.23M
P/E Ratio (TTM)67.81
Price to Sales (P/S)9.13
Price to Book (P/B)36.40
EV/EBITDA41.63
Revenue (TTM)4.29B
Net Income (TTM)577.22M
Free Cash Flow (TTM)643.34M
EPS (TTM)$4.26
Profit Margin13.46%
Operating Margin17.54%
Return on Equity (ROE)53.68%
Debt to Equity0.98
50-Day MA$294.27
200-Day MA$359.10
52-Week Change-12.79%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alnylam Pharmaceuticals

What is the current stock price for ALNY?

As of the latest trading session, ALNY stock trades at $266.99. The 52-week range is $266.43–$495.55, with a day range of $264.21–$273.71.

What is the P/E ratio for ALNY?

Alnylam Pharmaceuticals's trailing P/E ratio is 67.8, meaning investors pay $67.8 for every $1 of annual earnings. Alnylam Pharmaceuticals operates in the Healthcare sector.

Does ALNY pay dividends?

Alnylam Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALNY?

Based on 29 analysts, the consensus for ALNY is Buy.

What is the market cap of ALNY?

Alnylam Pharmaceuticals's market capitalization is $36.90B, classifying it as a large-cap company. Alnylam Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.